Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Primary sclerosing cholangitis

Inflammation to cancer in PSC

Nature Reviews Gastroenterology & Hepatology volume 20, page 559 (2023)Cite this article

Subjects

Antigen-driven inflammation promotes colorectal neoplasia in primary sclerosing cholangitis (PSC), a study published in Nature Medicine has shown. The insights into inflammatory processes could help to prevent colorectal cancer (CRC) in PSC.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

References

Original article

  • Shaw, D. G. et al. Antigen-driven colonic inflammation is associated with development of dysplasia in primary sclerosing cholangitis. Nat. Med. 29, 1520–1529 (2023)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nature Reviews Gastroenterology & Hepatology http://www.nature.com/nrgastro/

    Ian Fyfe

Authors
  1. Ian Fyfe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ian Fyfe.

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fyfe, I. Inflammation to cancer in PSC. Nat Rev Gastroenterol Hepatol 20, 559 (2023). https://doi.org/10.1038/s41575-023-00829-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41575-023-00829-5

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing